Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract

The mechanism(s) by which bacterial communities impact susceptibility to infectious diseases, such as HIV, and maintain female genital tract (FGT) health are poorly understood. Evaluation of FGT bacteria has predominantly been limited to studies of species abundance, but not bacterial function. We therefore sought to examine the relationship of bacterial community composition and function with mucosal epithelial barrier health in the context of bacterial vaginosis (BV) using metaproteomic, metagenomic, and in vitro approaches. We found highly diverse bacterial communities dominated by Gardnerella vaginalis associated with host epithelial barrier disruption and enhanced immune activation, and low diversity communities dominated by Lactobacillus species that associated with lower Nugent scores, reduced pH, and expression of host mucosal proteins important for maintaining epithelial integrity. Importantly, proteomic signatures of disrupted epithelial integrity associated with G. vaginalis-dominated communities in the absence of clinical BV diagnosis. Because traditional clinical assessments did not capture this, it likely represents a larger underrepresented phenomenon in populations with high prevalence of G. vaginalis. We finally demonstrated that soluble products derived from G. vaginalis inhibited wound healing, while those derived from L. iners did not, providing insight into functional mechanisms by which FGT bacterial communities affect epithelial barrier integrity.

[1]  R. McClelland,et al.  Vaginal microbiota and susceptibility to HIV , 2018, AIDS.

[2]  Corinne Rossi,et al.  Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease , 2016, Nature Immunology.

[3]  I. McGowan,et al.  HIV and mucosal barrier interactions: consequences for transmission and pathogenesis. , 2015, Current opinion in immunology.

[4]  J. Wastling,et al.  Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier , 2015, Mucosal Immunology.

[5]  D. Lauffenburger,et al.  Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells , 2015, Mucosal Immunology.

[6]  Douglas A. Lauffenburger,et al.  Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility , 2015, Journal of Virology.

[7]  R. McClelland,et al.  Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women. , 2015, The Journal of infectious diseases.

[8]  Melis N. Anahtar,et al.  Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. , 2015, Immunity.

[9]  Daniel Raftery,et al.  Metabolic Signatures of Bacterial Vaginosis , 2015, mBio.

[10]  B. Schittek,et al.  The secrets of dermcidin action. , 2015, International journal of medical microbiology : IJMM.

[11]  Massimo Deligios,et al.  A straightforward and efficient analytical pipeline for metaproteome characterization , 2014, Microbiome.

[12]  J. Marrazzo,et al.  Bacterial Vaginosis and the Cervicovaginal Immune Response , 2014, American journal of reproductive immunology.

[13]  C. Kenyon,et al.  The global epidemiology of bacterial vaginosis: a systematic review. , 2013, American journal of obstetrics and gynecology.

[14]  S. Turroni,et al.  Proteome profiles of vaginal fluids from women affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment. , 2013, The Journal of antimicrobial chemotherapy.

[15]  S. Lebeer,et al.  Vaginal microbiota and its role in HIV transmission and infection. , 2013, FEMS microbiology reviews.

[16]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[17]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[18]  Jeanne M. Marrazzo,et al.  Bacterial Communities in Women with Bacterial Vaginosis: High Resolution Phylogenetic Analyses Reveal Relationships of Microbiota to Clinical Criteria , 2012, PloS one.

[19]  Connie Celum,et al.  Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples , 2012, PLoS medicine.

[20]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[21]  G. Doncel,et al.  Innate Immunity and Inflammatory Response to Trichomonas vaginalis and Bacterial Vaginosis: Relationship to HIV Acquisition , 2011, American journal of reproductive immunology.

[22]  R. Brotman,et al.  Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. , 2010, The Journal of infectious diseases.

[23]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[24]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[25]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[26]  R. Knight,et al.  Bacterial Community Variation in Human Body Habitats Across Space and Time , 2009, Science.

[27]  J. Hocking,et al.  Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[29]  A. Adimora,et al.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies , 2008, AIDS.

[30]  J. Baeten,et al.  Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. , 2008, The Journal of infectious diseases.

[31]  R. Kaul,et al.  Stay it with flora: maintaining vaginal health as a possible avenue for prevention of human immunodeficiency virus acquisition. , 2008, The Journal of infectious diseases.

[32]  Zaid Abdo,et al.  Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women , 2007, The ISME Journal.

[33]  C. Liang,et al.  In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro , 2007, Nature Protocols.

[34]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[35]  J. Marrazzo,et al.  Molecular identification of bacteria associated with bacterial vaginosis. , 2005, The New England journal of medicine.

[36]  Rainer Schmidt,et al.  The cornified envelope: a model of cell death in the skin , 2005, Nature Reviews Molecular Cell Biology.

[37]  J. Wilson Managing recurrent bacterial vaginosis , 2004, Sexually Transmitted Infections.

[38]  JAMES L. Smith,et al.  The Physiological Role of Ferritin-Like Compounds in Bacteria , 2004, Critical reviews in microbiology.

[39]  S. Shott,et al.  Defense factors of vaginal lactobacilli. , 2001, American journal of obstetrics and gynecology.

[40]  B. Rittmann,et al.  The source of inoculum drives bacterial community structure in Synechocystis sp. PCC6803-based photobioreactors , 2016 .

[41]  M. Bissell Bacterial Vaginosis Assessed by Gram Stain and Diminished Colonization Resistance to Incident Gonococcal, Chlamydial, and Trichomonal Genital Infection , 2012 .

[42]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[43]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .